Click here to close now.

Welcome!

.NET Authors: Aria Blog, Pat Romanski, Elizabeth White, Hovhannes Avoyan, Sanjeev Sharma

News Feed Item

Express Scripts Reports Third Quarter Results

Raises Full Year Earnings Guidance

ST. LOUIS, Nov. 5, 2012 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced 2012 third quarter net income of $391.4 million, or $0.47 per diluted share.  Adjusted earnings per share, as detailed in Table 4 were $1.02 per diluted share for the third quarter.

"Our solid third quarter results demonstrate our continued success as a combined organization," stated George Paz, chairman and chief executive officer.  "Integration continues on track and together we are building on our legacy of advancing healthcare through innovation and an unwavering alignment with our clients."

Third Quarter 2012 Review (Data reflected on an adjusted basis. See Tables 2 and 3)

All key metrics compared to 2011 were affected by the inclusion of Medco results beginning in the second quarter of 2012.  Gross profit margin and EBITDA per adjusted claim increases over last year are mainly attributed to improved operating performance, including increased generic utilization.

  • Adjusted claims of 398.9 million, up 116% from third quarter 2011  
  • Gross profit of $2.2 billion, up 153% from third quarter 2011
  • Gross profit margin of 8.1% up from 7.5% in third quarter 2011
  • EBITDA of $1.6 billion, up 136% from third quarter 2011
  • EBITDA per adjusted claim of $4.06, up 9% from third quarter 2011
  • Year to date cash flow from operations of $2.0 billion, up 23% from third quarter 2011

2012 Guidance

Due to strong operating performance, increased generic utilization and the accelerated realization of synergies, the Company now expects to achieve adjusted earnings per share for 2012 in the range of $3.65 to $3.75.  Adjusted earnings per share excludes items as detailed in Table 5. 

Total adjusted claims are expected to be approximately 1.4 billion.  The guidance range assumes 2012 diluted weighted-average shares of 750 million.  Diluted weighted-average shares may differ due to, among other factors, the exercise of stock options and settlement of restricted stock units, and differences in the dilutive impact of awards granted under either of Express Scripts' or Medco's share-based compensation agreements.  The guidance range assumes a full year 2012 adjusted effective tax rate of approximately 39.6%.  Variations in assumed diluted weighted-average shares and tax rate may materially impact the guidance range.

The successful integration of Medco continues, with the Company meeting or exceeding its targets.

2013 Economic and Environmental Outlook

Express Scripts previously announced that it will provide 2013 guidance in conjunction with its fourth quarter results.  In addition to the expected claims loss from the UnitedHealthcare book of business throughout the year, the Company believes its 2013 outlook will also be influenced by the current weak business climate and the unemployment outlook.  These factors would likely result in significant in-group member attrition, continued low utilization rates and increased client demands and expectations.

Express Scripts expects to grow earnings per share and EBITDA in 2013.  However, given the factors discussed above, the Company views current consensus estimates for 2013 as overly aggressive.

"Despite near-term headwinds and a challenging macroeconomic environment, we remain confident we are well-positioned for continued growth", stated Paz.  "We have historically managed expenses rigorously while investing toward the future, focusing on innovation, service and optimal clinical outcomes, and will continue to do so, even when faced with challenges on other fronts."  

About Express Scripts

Express Scripts manages more than a billion prescriptions each year for tens of millions of people. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. We innovate to enhance patient care, reduce pharmacy-related waste and increase therapy adherence. Building on a strong clinical foundation, we apply our understanding of the behavioral sciences — an approach we call Consumerology® — to make it easier for people to choose better health.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit www.Express-Scripts.com or follow @ExpressScripts on Twitter.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements, including, but not limited to, statements related to the Company's plans, objectives, expectations (financial and otherwise) or intentions. Actual results may differ significantly from those projected or suggested in any forward-looking statements.  Factors that may impact these forward-looking statements can be found in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Form 10-Q filed with the SEC on or about November 5, 2012.  A copy of this form can be found at the Investor Relations section of Express Scripts' web site at http://www.express-scripts.com/corporate.

We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 EXPRESS SCRIPTS HOLDING COMPANY 

 Unaudited Consolidated Statement of Operations 










 Three Months Ended

September 30, 


 Nine Months Ended

September 30, 

(in millions, except per share data) 

2012


2011


2012


2011









Revenues(1)

$ 26,999.4


$ 11,571.0


$ 66,824.5


$ 34,026.9

Cost of revenues(1)

24,864.9


10,735.2


61,745.1


31,661.5

    Gross profit 

2,134.5


835.8


5,079.4


2,365.4

Selling, general and administrative

1,336.0


230.7


3,220.7


628.6

Operating income

798.5


605.1


1,858.7


1,736.8

Other (expense) income:








    Undistributed gain from joint venture 

5.1


-


9.4


-

    Interest income  

1.4


5.9


6.0


7.8

    Interest expense and other 

(155.9)


(94.3)


(463.1)


(184.3)


(149.4)


(88.4)


(447.7)


(176.5)

Income before income taxes

649.1


516.7


1,411.0


1,560.3

Provision for income taxes

257.7


192.0


602.2


574.9

Net income 

$      391.4


$      324.7


$      808.8


$      985.4









Weighted average number of common shares








 outstanding during the period: 








    Basic 

812.9


487.2


702.4


506.1

    Diluted 

829.6


490.8


718.9


510.3









Basic earnings per share

$        0.48


$        0.67


$        1.15


$        1.95









Diluted earnings per share

$        0.47


$        0.66


$        1.13


$        1.93









(1) Includes retail pharmacy co-payments of $3,348.9 million and $1,390.4 million for the three months ended September 30, 2012 and 2011, respectively and $8,364.6 million and $4,374.0 million for the nine months ended September 30, 2012 and 2011, respectively. 



 EXPRESS SCRIPTS HOLDING COMPANY 

 Unaudited Consolidated Balance Sheet 






 September 30,  


   December 31, 

 (in millions) 

2012


2011

 Assets 




 Current assets: 




 Cash and cash equivalents 

$          1,248.4


$       5,620.1

 Restricted cash and investments 

47.3


17.8

 Receivables, net 

5,720.3


1,915.7

 Inventories 

1,561.4


374.4

 Deferred taxes 

417.3


45.8

 Prepaid expenses and other current assets 

437.8


84.2

    Total current assets 

9,432.5


8,058.0

 Property and equipment, net 

1,710.2


416.2

 Goodwill 

29,367.5


5,485.7

 Other intangible assets, net 

16,735.9


1,620.9

 Other assets 

61.6


26.2

    Total assets 

$        57,307.7


$     15,607.0





 Liabilities and Stockholders' Equity 




 Current liabilities: 




 Claims and rebates payable 

$          6,710.0


$       2,874.1

 Accounts payable 

2,139.4


928.1

 Accrued expenses 

1,964.9


656.0

 Short-term loan payable 

40.0


-

 Current maturities of long-term debt 

938.6


999.9

    Total current liabilities 

11,792.9


5,458.1

 Long-term debt 

16,146.3


7,076.4

 Other liabilities 

6,623.6


598.8

    Total liabilities 

34,562.8


13,133.3





 Stockholders' Equity: 




 Preferred stock, 15.0 shares authorized, $0.01 par value per share;   



 and no shares issued and outstanding 

-


-

 Common stock, 2,985.0 shares authorized, $0.01 par value per share;  



 shares issued: 809.6 and 690.7, respectively; 




 shares outstanding: 809.6 and 484.6, respectively 

8.1


6.9

 Additional paid-in capital 

21,156.1


2,438.2

 Accumulated other comprehensive income 

16.6


17.0

 Retained earnings 

1,564.1


6,645.6


22,744.9


9,107.7





 Common stock in treasury at cost, zero and 206.1 shares, respectively 

-


(6,634.0)

    Total stockholders' equity 

22,744.9


2,473.7

    Total liabilities and stockholders' equity 

$        57,307.7


$     15,607.0









 EXPRESS SCRIPTS HOLDING COMPANY 

 Unaudited Consolidated Statement of Cash Flows 


 Nine Months Ended

September 30, 

 (in millions) 

2012


2011





 Cash flows from operating activities: 




 Net income  

$     808.8


$    985.4

 Adjustments to reconcile net income to net cash provided by operating activities: 




 Depreciation and amortization 

1,292.0


187.5

 Non-cash adjustments to net income 

37.8


152.9

 Deferred financing fees 

32.1


44.9

 Changes in operating assets and liabilities, net of effects of acquisition:  




 Accounts receivable 

382.6


(58.1)

 Claims and rebates payable 

(647.2)


44.4

 Other net changes in operating assets and liabilities 

143.3


302.9

 Net cash flows provided by operating activities 

2,049.4


1,659.9





 Cash flows from investing activities: 




 Acquisition of business, net of cash acquired 

(10,283.6)


-

 Purchases of property and equipment 

(106.0)


(98.1)

 Proceeds from sale of business 

31.5


-

 Other 

(16.2)


8.5

 Net cash used in investing activities 

(10,374.3)


(89.6)





 Cash flows from financing activities: 




 Proceeds from long-term debt, net of discounts 

7,458.9


1,494.0

 Repayment of long-term debt 

(2,710.6)


(0.1)

 Proceeds (repayment) of revolving credit line, net 

(1,000.0)


-

 Proceeds from accounts receivable financing facility 

600.0


-

 Repayment of accounts receivable financing facility 

(601.3)


-

 Excess tax benefit relating to employee stock compensation 

30.4


27.3

 Net proceeds from employee stock plans 

276.5


28.9

 Deferred financing fees 

(103.2)


(62.7)

 Treasury stock acquired 

-


(2,515.7)

 Net cash provided by (used in) financing activities 

3,950.7


(1,028.3)





 Effect of foreign currency translation adjustment 

2.5


(3.1)





 Net (decrease) increase in cash and cash equivalents 

(4,371.7)


538.9

 Cash and cash equivalents at beginning of period 

5,620.1


523.7

 Cash and cash equivalents at end of period 

$  1,248.4


$ 1,062.6









Table 1

Express Scripts Holding Company Unaudited Consolidated Selected Information

(in millions)










Three Months Ended

September 30,


Nine Months Ended

September 30,

Claims Volume

2012


2011


2012


2011

Network

282.9


147.2


721.5


444.0

Home delivery and specialty(1)

39.8


13.3


94.5


39.9

  Total claims

322.7


160.5


816.0


483.9









Total adjusted claims(2)

398.9


184.8


996.0


556.6









Depreciation and Amortization (D&A):








Revenue amortization(3)

$ 28.5


$ 28.5


$ 85.5


$ 85.5

Cost of revenues depreciation

39.4


9.6


76.5


31.2

Selling, general and administrative depreciation

47.9


13.1


121.7


40.3

Selling, general and administrative amortization

506.0


10.1


1,008.3


30.5

  Total D&A

$ 621.8


$ 61.3


$ 1,292.0


$ 187.5









Generic Fill Rate








Network

79.7%


75.3%


78.9%


75.2%

Home delivery

72.2%


63.0%


70.6%


62.5%

Overall

78.8%


74.1%


78.0%


74.0%









Note: See Appendix for footnotes.










Table 2

Calculation of Express Scripts Holding Company Adjusted Gross Profit and SG&A

(in millions)










Three Months Ended

September 30,


Nine Months Ended

September 30,


2012


2011


2012


2011

Gross profit, as reported

$ 2,134.5


$ 835.8


$ 5,079.4


$ 2,365.4

Amortization of legacy Express Scripts intangible assets (3)

28.5


28.5


85.5


85.5

Non-recurring transaction and integration costs (4)

21.8


-


33.7


-

Adjusted gross profit

$ 2,184.8


$ 864.3


$ 5,198.6


$ 2,450.9









Selling, general and administrative, as reported

$ 1,336.0


$ 230.7


$ 3,220.7


$ 628.6

Amortization of legacy Express Scripts intangible assets (3)

10.1


10.1


30.5


30.5

Amortization of Medco-related intangible assets (5)

495.9


-


977.8


-

Non-recurring transaction and integration costs (4)

179.1


20.3


586.1


20.3

Adjusted selling, general and administrative

$  650.9


$  200.3


$ 1,626.3


$  577.8









Note: See Appendix for footnotes.
















The Company is providing adjusted gross profit and selling, general and administrative expenses excluding the impact of non-recurring charges and amortization of intangible assets in order to compare the underlying financial performance to prior periods.

















Table 3

Express Scripts Holding Company EBITDA Reconciliation

(in millions, except per claim data)

 

The following is a reconciliation of net income to EBITDA(6). The Company believes net income is the most directly comparable measure calculated under U.S. GAAP.

 


Three Months Ended

September 30,


Nine Months Ended

September 30,



2012


2011


2012


2011


Net income, as reported

$    391.4


$  324.7


$   808.8


$    985.4


  Provision for income taxes

257.7


192.0


602.2


574.9


  Depreciation and amortization

621.8


61.3


1,292.0


187.5


  Interest expense, net

154.5


88.4


457.1


176.5


  Undistributed gain from joint venture

(5.1)


-


(9.4)


-


EBITDA, as reported

1,420.3


666.4


3,150.7


1,924.3


Non-recurring transaction and integration costs (4)

200.9


20.3


619.8


20.3


Adjusted EBITDA

$ 1,621.2


$ 686.7


$ 3,770.5


$ 1,944.6











Total adjusted claims

398.9


184.8


996.0


556.6











Adjusted EBITDA per adjusted claim

$      4.06


$   3.72


$      3.79


$      3.49











Note: See Appendix for footnotes.


















The Company is providing EBITDA excluding the impact of non-recurring charges in order to compare the underlying financial performance to prior periods.

 

Table 4

Calculation of Express Scripts Holding Company Adjusted EPS










Three Months Ended

September 30,


Nine Months Ended

September 30,


2012


2011


2012


2011


(per diluted share)

EPS, as reported

$ 0.47


$ 0.66


$ 1.13


$ 1.93









Non-recurring/transaction-related items:








Transaction and integration costs (4)

0.15


0.03


0.51


0.03

Medco acquisition pre-close financing costs (7)

-


0.05


0.07


0.05

Discrete tax items (8)

-


-


0.06


-









Amortization of:








Legacy Express Scripts intangible assets(3)

0.03


0.05


0.10


0.14

Medco-related intangible assets(5)

0.37


-


0.81


-









EPS, adjusted

$ 1.02


$ 0.79


$ 2.68


$ 2.15









Note: See Appendix for footnotes.
















The Company is providing diluted earnings per share excluding the impact of non-recurring / transaction-related items and amortization of intangible assets in order to compare the underlying financial performance to prior periods.

















Table 5

2012 Guidance Information


Estimated

Year Ended

December 31, 2012


(per diluted share)





Revised adjusted EPS guidance

$ 3.65

to

$ 3.75





GAAP items not included in guidance:








Amortization of legacy Express Scripts intangible assets

$0.12



Amortization of Medco-related intangible assets (9)

$1.19





Transaction and integration costs(10)

To be determined





The guidance range assumes 2012 diluted weighted-average shares of 750 million.  Diluted weighted-average shares may differ due to, among other factors, the exercise of stock options and settlement of restricted stock units, and differences in the dilutive impact of awards granted under either of Express Scripts' or Medco's share-based compensation agreements.  The guidance range assumes a full year 2012 adjusted effective tax rate of approximately 39.6%.  Variations in assumed diluted weighted-average shares and tax rate may materially impact the guidance range. 





 Note: See Appendix for footnotes.  












 Appendix 

 Footnotes 


(1)Includes home delivery, specialty and other including:  (a) drugs distributed through patient assistance programs (b) drugs we distribute to other PBMs' clients under limited distribution contracts with pharmaceutical manufacturers and (c) FreedomFP claims. 


(2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims typically cover a time period 3 times longer than retail claims. 


(3) Amortization of legacy Express Scripts intangible assets include amounts in both revenues and selling, general and administrative expense. Revenue amortization is related to the customer contract with WellPoint which consummated upon closing of the NextRx acquisition in 2009.  Under U.S. GAAP standards, amortization of intangibles that arise in connection with consideration given to a customer by a vendor is characterized as a reduction of revenues.  Intangible amortization of $28.5 million ($17.6 million and $17.9 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the three months ended September 30, 2012 and 2011.   Intangible amortization of $85.5 million ($51.2 million and $54.0 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the nine months ended September 30, 2012 and 2011.  


In addition, intangible amortization of $10.1 million ($6.3 million net of tax) is included in selling, general and administrative expense in the three months ended September 30, 2012 and 2011. Intangible amortization of $30.5 million ($18.3 million and $19.3 million net of tax in 2012 and 2011, respectively) is included in selling, general and administrative expense in the nine months ended September 30, 2012 and 2011.


(4) Non-recurring transaction and integration costs include those directly related to the acquisition of Medco Health Solutions, Inc. ("Medco").   


Costs of $21.8 million ($13.5 million net of tax) and $33.7 million ($20.2 million net of tax) for the three months and nine months ended September 30, 2012, respectively, primarily composed of integration-related activities, are included in cost of revenues.


Costs of $158.9 million ($98.4 million net of tax) and $20.3 million ($12.8 million net of tax) primarily composed of severance costs, including stock compensation, are included in selling, general and administrative expense in the three months ended September 30, 2012 and 2011, respectively. Costs of $565.9 million ($339.0 million net of tax) and $20.3 million ($12.8 million net of tax) are included in selling, general and administrative expense in the nine months ended September 30, 2012 and 2011, respectively.


The Company recorded net charges of $20.2 million ($12.5 million and $12.1 million net of tax in the three months and nine months, respectively) within selling, general and administrative expenses for the three months and nine months ended September 30, 2012 in conjunction with the strategic decision to exit various businesses.


(5) Amortization of intangible assets related to the acquisition of Medco of $495.9 million ($307.0 million net of tax) and $977.8 million ($585.7 million net of tax) for the three months and nine months ended September 30, 2012, respectively is included in selling, general and administrative expense. 


(6)EBITDA is earnings before taxes, depreciation and amortization, net interest and other income (expense); or alternatively calculated as operating income plus depreciation and amortization.  EBITDA is presented because it is a widely accepted indicator of a company's ability to service indebtedness and is frequently used to evaluate a company's performance.  EBITDA, however, should not be considered as an alternative to net income, as a measure of operating performance, as an alternative to cash flow, as a measure of liquidity or as a substitute for any other measure computed in accordance with U.S. GAAP. In addition, this definition and calculation of EBITDA may not be comparable to that used by other companies.


(7)Financing costs include fees related to the amortization of remaining bridge loan fees, commitment fees related to the new credit agreement and interest and fees on the senior notes secured in conjunction with the acquisition of Medco.  Costs of $42.0 million ($26.4 million net of tax) are included interest expense in the three months ended September 30, 2011.  Costs of $85.2 million ($51.0 million net of tax) and $42.0 million ($26.5 million net of tax) are included in interest expense in the nine months ended September 30, 2012 and 2011, respectively. 


(8)Provision for income taxes includes discrete tax items of $43.5 million for the nine months ended September 30, 2012. These items primarily relate to adjustments to prior year income tax return filings and a reversal of the deferred tax asset previously established for transaction-related costs that became nondeductible upon the consummation of the Merger.  


(9) Adjusted EPS will exclude amortization of Medco-related intangible assets.  The current estimate of full year amortization based on the preliminary purchase price allocation.  The preliminary purchase price allocation may be subject to further refinement and may result in significant changes.  


(10) Adjusted EPS will exclude Medco-related transaction and integration costs. The full-year impact of these costs have yet to be determined. 

 

SOURCE Express Scripts

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
Roberto Medrano, Executive Vice President at SOA Software, had reached 30,000 page views on his home page - http://RobertoMedrano.SYS-CON.com/ - on the SYS-CON family of online magazines, which includes Cloud Computing Journal, Internet of Things Journal, Big Data Journal, and SOA World Magazine. He is a recognized executive in the information technology fields of SOA, internet security, governance, and compliance. He has extensive experience with both start-ups and large companies, having been involved at the beginning of four IT industries: EDA, Open Systems, Computer Security and now SOA.
SYS-CON Events announced today that GENBAND, a leading developer of real time communications software solutions, has been named “Silver Sponsor” of SYS-CON's WebRTC Summit, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. The GENBAND team will be on hand to demonstrate their newest product, Kandy. Kandy is a communications Platform-as-a-Service (PaaS) that enables companies to seamlessly integrate more human communications into their Web and mobile applications - creating more engaging experiences for their customers and boosting collaboration and productiv...
When it comes to the Internet of Things, hooking up will get you only so far. If you want customers to commit, you need to go beyond simply connecting products. You need to use the devices themselves to transform how you engage with every customer and how you manage the entire product lifecycle. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, will show how “product relationship management” can help you leverage your connected devices and the data they generate about customer usage and product performance to deliver extremely compelling and reliabl...
From telemedicine to smart cars, digital homes and industrial monitoring, the explosive growth of IoT has created exciting new business opportunities for real time calls and messaging. In his session at @ThingsExpo, Ivelin Ivanov, CEO and Co-Founder of Telestax, shared some of the new revenue sources that IoT created for Restcomm – the open source telephony platform from Telestax. Ivelin Ivanov is a technology entrepreneur who founded Mobicents, an Open Source VoIP Platform, to help create, deploy, and manage applications integrating voice, video and data. He is the co-founder of TeleStax, a...
The industrial software market has treated data with the mentality of “collect everything now, worry about how to use it later.” We now find ourselves buried in data, with the pervasive connectivity of the (Industrial) Internet of Things only piling on more numbers. There’s too much data and not enough information. In his session at @ThingsExpo, Bob Gates, Global Marketing Director, GE’s Intelligent Platforms business, to discuss how realizing the power of IoT, software developers are now focused on understanding how industrial data can create intelligence for industrial operations. Imagine ...
Operational Hadoop and the Lambda Architecture for Streaming Data Apache Hadoop is emerging as a distributed platform for handling large and fast incoming streams of data. Predictive maintenance, supply chain optimization, and Internet-of-Things analysis are examples where Hadoop provides the scalable storage, processing, and analytics platform to gain meaningful insights from granular data that is typically only valuable from a large-scale, aggregate view. One architecture useful for capturing and analyzing streaming data is the Lambda Architecture, representing a model of how to analyze rea...
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - is now accepting submissions to demo smart cars on the Expo Floor. Smart car sponsorship benefits include general brand exposure and increasing engagement with the developer ecosystem.
SYS-CON Events announced today that Vitria Technology, Inc. will exhibit at SYS-CON’s @ThingsExpo, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Vitria will showcase the company’s new IoT Analytics Platform through live demonstrations at booth #330. Vitria’s IoT Analytics Platform, fully integrated and powered by an operational intelligence engine, enables customers to rapidly build and operationalize advanced analytics to deliver timely business outcomes for use cases across the industrial, enterprise, and consumer segments.
When it comes to the Internet of Things, hooking up will get you only so far. If you want customers to commit, you need to go beyond simply connecting products. You need to use the devices themselves to transform how you engage with every customer and how you manage the entire product lifecycle. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, will show how “product relationship management” can help you leverage your connected devices and the data they generate about customer usage and product performance to deliver extremely compelling and reliabl...
SYS-CON Events announced today that SoftLayer, an IBM company, has been named “Gold Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place June 9-11, 2015 at the Javits Center in New York City, NY, and the 17th International Cloud Expo®, which will take place November 3–5, 2015 at the Santa Clara Convention Center in Santa Clara, CA. SoftLayer operates a global cloud infrastructure platform built for Internet scale. With a global footprint of data centers and network points of presence, SoftLayer provides infrastructure as a service to leading-edge customers ranging from ...
The explosion of connected devices / sensors is creating an ever-expanding set of new and valuable data. In parallel the emerging capability of Big Data technologies to store, access, analyze, and react to this data is producing changes in business models under the umbrella of the Internet of Things (IoT). In particular within the Insurance industry, IoT appears positioned to enable deep changes by altering relationships between insurers, distributors, and the insured. In his session at @ThingsExpo, Michael Sick, a Senior Manager and Big Data Architect within Ernst and Young's Financial Servi...
SYS-CON Events announced today that Open Data Centers (ODC), a carrier-neutral colocation provider, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place June 9-11, 2015, at the Javits Center in New York City, NY. Open Data Centers is a carrier-neutral data center operator in New Jersey and New York City offering alternative connectivity options for carriers, service providers and enterprise customers.
The IoT market is projected to be $1.9 trillion tidal wave that’s bigger than the combined market for smartphones, tablets and PCs. While IoT is widely discussed, what not being talked about are the monetization opportunities that are created from ubiquitous connectivity and the ensuing avalanche of data. While we cannot foresee every service that the IoT will enable, we should future-proof operations by preparing to monetize them with extremely agile systems.
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. Learn about IoT, Big Data and deployments processing massive data volumes from wearables, utilities and other machines.
SYS-CON Events announced today that CodeFutures, a leading supplier of database performance tools, has been named a “Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. CodeFutures is an independent software vendor focused on providing tools that deliver database performance tools that increase productivity during database development and increase database performance and scalability during production.
The explosion of connected devices / sensors is creating an ever-expanding set of new and valuable data. In parallel the emerging capability of Big Data technologies to store, access, analyze, and react to this data is producing changes in business models under the umbrella of the Internet of Things (IoT). In particular within the Insurance industry, IoT appears positioned to enable deep changes by altering relationships between insurers, distributors, and the insured. In his session at @ThingsExpo, Michael Sick, a Senior Manager and Big Data Architect within Ernst and Young's Financial Servi...
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud strategy and programs. In this Power Panel at 15th Cloud Expo (http://www.CloudComputingExpo.com), moderated by Ashar Baig, Research Director, Cloud, at Gigaom Research, Nate Gordon, Director of T...
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," explained Peter Dunkley, Technical Director at Acision, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Intelligent Systems Services will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Established in 1994, Intelligent Systems Services Inc. is located near Washington, DC, with representatives and partners nationwide. ISS’s well-established track record is based on the continuous pursuit of excellence in designing, implementing and supporting nationwide clients’ mission-critical systems. ISS has completed many successful projects in Healthcare, Commercial, Manufacturing, ...
PubNub on Monday has announced that it is partnering with IBM to bring its sophisticated real-time data streaming and messaging capabilities to Bluemix, IBM’s cloud development platform. “Today’s app and connected devices require an always-on connection, but building a secure, scalable solution from the ground up is time consuming, resource intensive, and error-prone,” said Todd Greene, CEO of PubNub. “PubNub enables web, mobile and IoT developers building apps on IBM Bluemix to quickly add scalable realtime functionality with minimal effort and cost.”